136 related articles for article (PubMed ID: 31599407)
1. MiRNA-206 inhibits proliferation of renal clear cell carcinoma by targeting ZEB2.
Chen XF; Guo JF; Xu JF; Yin SH; Cao WL
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7826-7834. PubMed ID: 31599407
[TBL] [Abstract][Full Text] [Related]
2. miRNA-217 inhibits proliferation of hepatocellular carcinoma cells by regulating KLF5.
Gao W; Lu YX; Wang F; Sun J; Bian JX; Wu HY
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7874-7883. PubMed ID: 31599412
[TBL] [Abstract][Full Text] [Related]
3. MiRNA-8073 targets ZnT1 to inhibit malignant progression of ovarian cancer.
Zhang L; Wang YH; Wang L
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(14):6062-6069. PubMed ID: 31364107
[TBL] [Abstract][Full Text] [Related]
4. miRNA-205 is a candidate tumor suppressor that targets ZEB2 in renal cell carcinoma.
Chen Z; Tang ZY; He Y; Liu LF; Li DJ; Chen X
Oncol Res Treat; 2014; 37(11):658-64. PubMed ID: 25427583
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-140 Represses Esophageal Cancer Progression via Targeting ZEB2 to Regulate Wnt/β-Catenin Pathway.
Yang S; Li X; Shen W; Hu H; Li C; Han G
J Surg Res; 2021 Jan; 257():267-277. PubMed ID: 32862055
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA ZEB2-AS1 expression is associated with disease progression and predicts outcome in gastric cancer patients.
Xu C; Cui H; Li H; Wu Y; An H; Guo C
J BUON; 2019; 24(2):663-671. PubMed ID: 31128021
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-328-3p inhibits malignant progression of hepatocellular carcinoma by regulating MMP-9 level.
Li JZ; Li J; Liu BZ
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9331-9340. PubMed ID: 31773692
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-129-5p inhibits invasiveness and metastasis of lung cancer cells and tumor angiogenesis via targeting VEGF.
Cheng XK; Lin WR; Jiang H; Su ZH; Li L; Wang J
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2827-2837. PubMed ID: 31002164
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-625-3p inhibits gastric cancer metastasis through modulating EZH2.
Li Y; Zhou HC; Zhang Y; Huang H
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1177-1185. PubMed ID: 32096165
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-424-5p inhibits the development of non-small cell LCa by binding to ITGB1.
Xu ZL; Zhang M; Chen SX; Qiu M; Zhang Q; Gao LP; Li JDX
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8921-8930. PubMed ID: 31696479
[TBL] [Abstract][Full Text] [Related]
11. Three LHPP gene-targeting co-expressed microRNAs (microRNA-765, microRNA-21, and microRNA-144) promote proliferation, epithelial-mesenchymal transition, invasion, and are independent prognostic biomarkers in renal cell carcinomas patients.
Meng K; Li Z; Cui X
J Clin Lab Anal; 2021 Dec; 35(12):e24077. PubMed ID: 34699621
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-548c-5p inhibits the proliferation of breast cancer cells through regulating Wnt/β-catenin signaling pathway.
He SZ; Wang Q
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3795-3804. PubMed ID: 32329856
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-200c regulates cisplatin resistance by targeting ZEB2 in human gastric cancer cells.
Jiang T; Dong P; Li L; Ma X; Xu P; Zhu H; Wang Y; Yang B; Liu K; Liu J; Xue J; Lv R; Su P; Kong G; Chang Y; Zhao C; Wang L
Oncol Rep; 2017 Jul; 38(1):151-158. PubMed ID: 28534959
[TBL] [Abstract][Full Text] [Related]
14. LncRNA HOXA-AS2 regulates microRNA-216a-5p to promote malignant progression of non-small cell lung cancer.
Cui TJ; Lin GS; Dai YM; Zheng JP; Chen Z; Chen Q; Zheng Y; Lin X
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):264-273. PubMed ID: 31389597
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of microRNA-15a suppresses the proliferation and invasion of renal cell carcinoma via direct targeting of eIF4E.
Li G; Chong T; Xiang X; Yang J; Li H
Oncol Rep; 2017 Oct; 38(4):1995-2002. PubMed ID: 28849086
[TBL] [Abstract][Full Text] [Related]
16. miR‑539 suppresses proliferation and induces apoptosis in renal cell carcinoma by targeting high mobility group A2.
Ye ZH; Gui DW
Mol Med Rep; 2018 Apr; 17(4):5611-5618. PubMed ID: 29436648
[TBL] [Abstract][Full Text] [Related]
17. Circ_0001247 functions as a miR-1270 sponge to accelerate cervical cancer progression by up-regulating ZEB2 expression level.
Wang W; Xu A; Zhao M; Sun J; Gao L
Biotechnol Lett; 2021 Mar; 43(3):745-755. PubMed ID: 33386495
[TBL] [Abstract][Full Text] [Related]
18. CircPCNXL2 sponges miR-153 to promote the proliferation and invasion of renal cancer cells through upregulating ZEB2.
Zhou B; Zheng P; Li Z; Li H; Wang X; Shi Z; Han Q
Cell Cycle; 2018; 17(23):2644-2654. PubMed ID: 30488762
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-99a induces G1-phase cell cycle arrest and suppresses tumorigenicity in renal cell carcinoma.
Cui L; Zhou H; Zhao H; Zhou Y; Xu R; Xu X; Zheng L; Xue Z; Xia W; Zhang B; Ding T; Cao Y; Tian Z; Shi Q; He X
BMC Cancer; 2012 Nov; 12():546. PubMed ID: 23173671
[TBL] [Abstract][Full Text] [Related]
20. LncRNA MINCR promotes the development of liver cancer by regulating microRNA-107/β-catenin.
Li H; Yuan R; Wang H; Li C; Wei J
J BUON; 2020; 25(2):972-980. PubMed ID: 32521894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
